New treatment for young children with parasitic disease schistosomiasis

View source ↗

Summary

EMA CHMP adopted a positive scientific opinion for Arpraziquantel to treat schistosomiasis in young children aged 3 months to 6 years.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis

Drugs mentioned

• Arpraziquantel (arpraziquantel)

Snippet

EMA’s human medicines committee (CHMP) has adopted a positive scientific opinion for Arpraziquantel used to treat schistosomiasis in young children aged 3 months to 6 years.